Search

Author/Creator Biondani, P.

1. Detecting actionable PIK3CA mutations through next-generation sequencing (NGS) in hormone receptor positive (HR+)/HER2-negative advanced/metastatic breast cancer (MBC): a real-life experience. (November 2022)

Authors:
Caldart, A.; Fiorio, E.; Zanelli, S.; Biondani, P.; Parolin, V.; Pellini, F.; Montemezzi, S.; Nottegar, A.; Caliò, A.; Zampiva, I.; Merler, S.; Mongillo, M.; Avesani, B.; Borghesani, G.; Giontella, E.; Scarpa, A.; Milella, M.
Journal:
European journal of cancer
Issue:
Volume 175(2022)Supplement 1
Page Start:
S38
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search